21st.Bio files EU Novel Food application for fermented milk protein
Danish biotech 21st.Bio has submitted an EU Novel Food application for BLG Essential+, a precision-fermented bovine beta-lactoglobulin. The filing follows a US FDA GRAS clearance and targets European whey protein supply constraints with a lower-resource alternative to dairy.
Danish biotech company 21st.Bio has filed an EU Novel Food application for BLG Essential+, its bovine milk protein beta-lactoglobulin. The filing follows a US FDA GRAS clearance for the precision-fermented ingredient obtained in October 2025. Application Details According to PR Newswire, the application marks a significant step toward producing high-quality proteins in Europe with fewer resources while helping address supply constraints in the European whey protein market. When approved by EFSA, BLG Essential+ can enable resource-efficient milk protein production and sale in Europe using industrially proven precision fermentation technology. Nutrition Insight notes the application was submitted to the European Commission for safety assessment by the European Food Safety Authority, and that 21st.Bio self-affirmed the ingredient's GRAS status in September 2024. BLG Essential+ is produced using Aspergillus oryzae, a microorganism used for centuries in Japanese food fermentation, including soy sauce and miso, as reported by PR Newswire. The production platform has been developed and refined over decades by Novonesis and further advanced by 21st.Bio for safe, efficient food protein production at massive scale. PR Newswire adds that a 2025 peer-reviewed study in Applied Microbiology and Biotechnology described the strain lineage as the first mycotoxin-free A. oryzae lineage for industrial production of alternative and novel proteins. Protein Benefits and Market Demand BLG is the predominant protein in whey protein from milk, and is valued for its high-quality amino-acid profile and versatile functionality, according to PR Newswire. The company states that BLG Essential+ is essentially a copy of the best protein in milk produced through precision fermentation. PR Newswire notes that BLG is the protein you would want to offer to elderly and sick people who need nutritional support for muscle maintenance, building and recovery, as well as people on weight-loss medication seeking to maintain and build muscle while losing fat. It is also ideally suited for compact nutrition for people on the go, in conflict zones, or travelling to Mars. Nutrition Insight adds that the ingredient offers a scalable, resource-efficient whey alternative tailored for clinical nutrition, people on weight-loss medication, and compact food formats. Regulatory Calls and European Industry Thomas G. Schmidt, co-founder and CEO of 21st.Bio, stated that Europe has the science, the companies, and the industrial heritage in precision fermentation to lead the wave of healthy and nutritious food production. PR Newswire notes that preparing a full EU dossier has required years of scientific and procedural work and significant investment from 21st.Bio, while the subsequent approval process and timeline make it tough for innovators and manufacturers to plan investments, facilities and launch products in Europe. Both Nutrition Insight and PR Newswire state that 21st.Bio is urging European regulators to create a faster, more predictable approval pathway for nature-identical proteins to retain biotech manufacturing and investment. Schmidt stated that this is not a choice between safety and speed, but an opportunity to apply the best science to achieve both. PR Newswire notes that approval of this technology can unlock significant investment and enable establishment of industrial production facilities across Europe, creating jobs for workers and strengthening European equipment manufacturers, process-design companies, and scientific leadership.
Read source: Nutrition Insight